Julie Lemieux1, Elizabeth Maunsell, Louise Provencher. 1. Unité de recherche en santé des populations, Centre hospitalier affilié universitaire de Québec, Quebec, Que, Canada. julie.lemieux@uresp.ulaval.ca
Abstract
BACKGROUND: Alopecia is a common side effect of chemotherapies used in the treatment of breast cancer. The aim of this review is to describe the effects of alopecia on quality of life (QOL) in this population. METHODS: We conducted a literature review using Medline, Embase, Cumulative Index to Nursing and Allied Health Literature and PsycInfo databases. We searched for studies on the effects of alopecia on various aspects of QOL in breast cancer patients including anxiety and distress, body image, sexuality, self-esteem, social functioning, global QOL and return to work outcomes. RESULTS: A total of 38 articles were included in the review. Hair loss consistently ranked amongst the most troublesome side effects, was described as distressing, and may affect the body image. CONCLUSIONS: We found very little quantitative data on other aspects of QOL. More research is needed to determine the presence and extent of negative effects on chemotherapy-induced alopecia on various aspects of QOL. Copyright 2007 John Wiley & Sons, Ltd.
BACKGROUND:Alopecia is a common side effect of chemotherapies used in the treatment of breast cancer. The aim of this review is to describe the effects of alopecia on quality of life (QOL) in this population. METHODS: We conducted a literature review using Medline, Embase, Cumulative Index to Nursing and Allied Health Literature and PsycInfo databases. We searched for studies on the effects of alopecia on various aspects of QOL in breast cancerpatients including anxiety and distress, body image, sexuality, self-esteem, social functioning, global QOL and return to work outcomes. RESULTS: A total of 38 articles were included in the review. Hair loss consistently ranked amongst the most troublesome side effects, was described as distressing, and may affect the body image. CONCLUSIONS: We found very little quantitative data on other aspects of QOL. More research is needed to determine the presence and extent of negative effects on chemotherapy-induced alopecia on various aspects of QOL. Copyright 2007 John Wiley & Sons, Ltd.
Authors: T C Wikramanayake; S Amini; J Simon; L M Mauro; G Elgart; L A Schachner; J J Jimenez Journal: Clin Exp Dermatol Date: 2012-04 Impact factor: 3.470
Authors: Hope S Rugo; Paula Klein; Susan Anitra Melin; Sara A Hurvitz; Michelle E Melisko; Anne Moore; Glen Park; Jules Mitchel; Erika Bågeman; Ralph B D'Agostino; Elizabeth S Ver Hoeve; Laura Esserman; Tessa Cigler Journal: JAMA Date: 2017-02-14 Impact factor: 56.272
Authors: Elizabeth L McGarvey; Maguadalupe Leon-Verdin; Lora D Baum; Karen Bloomfield; David R Brenin; Cheryl Koopman; Scott Acton; Brian Clark; B Eugene Parker Journal: Psychooncology Date: 2010-07 Impact factor: 3.894
Authors: Manon M C Komen; Corina J G van den Hurk; Johan W R Nortier; Tjeerd van der Ploeg; P Nieboer; Jacobus J M van der Hoeven; Carolien H Smorenburg Journal: Support Care Cancer Date: 2018-09-11 Impact factor: 3.603
Authors: Joanne M Shaw; Jane O'Brien; Susan Chua; Richard De Boer; Rachel Dear; Nicholas Murray; Fran Boyle Journal: Support Care Cancer Date: 2017-08-29 Impact factor: 3.603